35 related articles for article (PubMed ID: 9126230)
1. Evaluation of PSA-age volume score in predicting prostate cancer in Chinese population.
Wu YS; Wu XB; Zhang N; Jiang GL; Yu Y; Tong SJ; Jiang HW; Mao SH; Na R; Ding Q
Asian J Androl; 2018; 20(4):324-329. PubMed ID: 29405172
[TBL] [Abstract][Full Text] [Related]
2. Assessment of PSA-Age volume score in predicting positive prostate biopsy findings in Turkey.
Uçer O; Yücetas U; Çelen I; Toktas G; Müezzinoglu T
Int Braz J Urol; 2015; 41(5):864-8. PubMed ID: 26689512
[TBL] [Abstract][Full Text] [Related]
3. The value of an artificial neural network in the decision-making for prostate biopsies.
Meijer RP; Gemen EF; van Onna IE; van der Linden JC; Beerlage HP; Kusters GC
World J Urol; 2009 Oct; 27(5):593-8. PubMed ID: 19562346
[TBL] [Abstract][Full Text] [Related]
4. Effect of thrombin tube on PSA determination, a clue for false negative in screening for prostate cancer.
Wiwanitkit V
J Thromb Thrombolysis; 2009 Feb; 27(2):223-6. PubMed ID: 18297239
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic efficacy of free to total ratio of prostate-specific antigen and prostate-specific antigen velocity, singly and in combination, in detecting prostate cancer in patients with total serum prostate-specific antigen between 4 and 10 ng/ml.
Yamamoto S; Maruyama T; Kondoh N; Nojima M; Takiuchi H; Hirota S; Shima H
Int Urol Nephrol; 2008; 40(1):85-9. PubMed ID: 17619162
[TBL] [Abstract][Full Text] [Related]
6. [The role of PSA in diagnosis of prostate cancer and its recurrence].
Vergho DC; Heine K; Wolff JM
Pathologe; 2005 Nov; 26(6):473-8. PubMed ID: 16215709
[TBL] [Abstract][Full Text] [Related]
7. Advances in the application of prostate-specific antigen in the detection of early-stage prostate cancer.
Kamoi K; Babaian RJ
Semin Oncol; 1999 Apr; 26(2):140-9. PubMed ID: 10597725
[TBL] [Abstract][Full Text] [Related]
8. [Prostate cancer].
Uchida K; Akaza H
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1469-74. PubMed ID: 11681260
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen density.
Beduschi MC; Oesterling JE
Urol Clin North Am; 1997 May; 24(2):323-32. PubMed ID: 9126230
[TBL] [Abstract][Full Text] [Related]
10. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
[TBL] [Abstract][Full Text] [Related]
11. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence.
Rahardjo D; Kamil ST; Pakasi LS
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():563-70. PubMed ID: 10895211
[TBL] [Abstract][Full Text] [Related]
12. Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men.
Sheikh M; Al-Saeed O; Kehinde EO; Sinan T; Anim JT; Ali Y
Int Urol Nephrol; 2005; 37(4):721-6. PubMed ID: 16362587
[TBL] [Abstract][Full Text] [Related]
13. An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density.
Benson MC; McMahon DJ; Cooner WH; Olsson CA
World J Urol; 1993; 11(4):206-13. PubMed ID: 7508785
[TBL] [Abstract][Full Text] [Related]
14. Prostate specific antigen density for discriminating prostate cancer from benign prostatic hyperplasia in the gray zone of prostate-specific antigen.
Uno H; Koide T; Kuriyama M; Ban Y; Deguchi T; Kawada Y
Hinyokika Kiyo; 1999 Jul; 45(7):457-61. PubMed ID: 10466060
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
